» Articles » PMID: 39200370

Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases

Overview
Journal Biomedicines
Date 2024 Aug 29
PMID 39200370
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary neurodegenerative diseases (hNDDs) such as Alzheimer's, Parkinson's, Huntington's disease, and others are primarily characterized by their progressive nature, severely compromising both the cognitive and motor abilities of patients. The underlying genetic component in hNDDs contributes to disease risk, creating a complex genetic landscape. Considering the fact that growth factors play crucial roles in regulating cellular processes, such as proliferation, differentiation, and survival, they could have therapeutic potential for hNDDs, provided appropriate dosing and safe delivery approaches are ensured. This article presents a detailed overview of growth factors, and explores their therapeutic potential in treating hNDDs, emphasizing their roles in neuronal survival, growth, and synaptic plasticity. However, challenges such as proper dosing, delivery methods, and patient variability can hinder their clinical application.

Citing Articles

The Potential Role of Adipose-Derived Stem Cells in Regeneration of Peripheral Nerves.

Mohan S, Priya S, Tawfig N, Padmanabhan V, Babiker R, Palaniappan A Neurol Int. 2025; 17(2).

PMID: 39997654 PMC: 11858299. DOI: 10.3390/neurolint17020023.


Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders.

Sivalingam A, Sureshkumar D Mol Neurobiol. 2025; .

PMID: 39918711 DOI: 10.1007/s12035-025-04733-8.

References
1.
Whone A, Luz M, Boca M, Woolley M, Mooney L, Dharia S . Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease. Brain. 2019; 142(3):512-525. PMC: 6391602. DOI: 10.1093/brain/awz023. View

2.
Karami A, Eyjolfsdottir H, Vijayaraghavan S, Lind G, Almqvist P, Kadir A . Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease. Alzheimers Dement. 2015; 11(11):1316-28. DOI: 10.1016/j.jalz.2014.11.008. View

3.
Rauniyar K, Bokharaie H, Jeltsch M . Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis. 2023; 26(3):437-461. PMC: 10328876. DOI: 10.1007/s10456-023-09874-9. View

4.
Tapia-Gonzalez S, Giraldez-Perez R, Cuartero M, Casarejos M, Mena M, Wang X . Dopamine and α-synuclein dysfunction in Smad3 null mice. Mol Neurodegener. 2011; 6:72. PMC: 3219599. DOI: 10.1186/1750-1326-6-72. View

5.
Forrest S, Kovacs G . Current Concepts of Mixed Pathologies in Neurodegenerative Diseases. Can J Neurol Sci. 2022; 50(3):329-345. DOI: 10.1017/cjn.2022.34. View